Wall Street Zen Downgrades Iron Mountain (NYSE:IRM) to Hold
📉 Wall Street Zen downgraded Iron Mountain from 'buy' to 'hold' on July 25th, 2026.
📈 JPMorgan Chase raised its price target to $138.00 with an 'overweight' rating in May.
💰 Q1 earnings beat estimates with $0.60 EPS and revenue of $1.94 billion, up 21.5% YoY.
📅 Q2 2026 guidance set at $1.40-$1.40 EPS; FY 2026 guidance at $5.79-$5.86 EPS.
🏦 Cohen & Steers boosted its position by 20% in the fourth quarter to own ~$1.57B worth of stock.
📉 Director Pamela Arway sold 1,892 shares for $244k and CAO Daniel Borges sold 7,189 shares for $902k.
🏛️ Institutional ownership stands at 80.13% with major funds like UBS and Principal increasing stakes.
🎯 Consensus analyst rating is 'Moderate Buy' with an average price target of $134.33.
Bullish Signals
- Iron Mountain reported Q1 EPS of $0.60, beating the consensus estimate of $0.50 by $0.10.
- Revenue reached $1.94 billion, surpassing the $1.86 billion consensus and growing 21.5% year-over-year.
- JPMorgan Chase raised its price target to $138.00 and maintained an 'overweight' rating in May.
- Cohen & Steers Inc. increased its position by 20% in the fourth quarter, adding over $315M in value.
- UBS Asset Management Americas grew its holdings by nearly 600% in the third quarter.
- Principal Financial Group increased its stake by 66.5% in the fourth quarter.
- The company maintains a consensus 'Moderate Buy' rating with an average analyst price target of $134.33.
Risk Factors
- Wall Street Zen downgraded the stock from 'buy' to 'hold', signaling caution despite recent earnings beats.
- Insiders sold a total of 137,260 shares valued at $17.36 million in the last ninety days.
- The company reported a negative return on equity of -91.56% for the quarter.
Full Analysis
Wall Street Zen downgraded Iron Mountain (NYSE:IRM) from a 'buy' to a 'hold' rating in a report issued on Saturday, July 25th, 2026. This action contrasts with recent bullish sentiment from other major institutions, including JPMorgan Chase, Wells Fargo, Truist Financial, and Barclays, which have all raised their price targets or maintained overweight ratings between April and July.
The company reported strong quarterly financial results ending April 30th, posting $0.60 in earnings per share (EPS) against a consensus of $0.50 and generating $1.94 billion in revenue versus an estimate of $1.86 billion. Revenue grew 21.5% year-over-year to $1.94 billion, though the firm reported a negative return on equity of 91.56% and a net margin of 3.76%. Management provided guidance for Q2 2026 EPS between $1.40 and $1.40 and full-year 2026 EPS between $5.79 and $5.86.
Insider trading activity shows mixed signals, with Director Pamela Arway and CAO Daniel Borges selling shares totaling over $24 million in May under pre-arranged Rule 10b5-1 plans, while institutional investors like Cohen & Steers and UBS significantly increased their holdings in the fourth quarter. The stock currently carries a consensus 'Moderate Buy' rating with an average price target of $134.33.
